Cognito Therapeutics Group, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCambridge, MA
US patents19
SAM.gov UEIH7Z3B8BU47J4
CAGE code15Q77
Incorporated inDE
- Spectris
- audiovisual stimulation
- clinical studies
- OVERTURE
- disease progression
- preservation
- cognition
- function
- brain volume
Named on the company’s own website, read JUL 29, 2026
Open positions
Openings read from Cognito Therapeutics Group, INC.’s own job board on Ashby, last checked NOV 2, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Senior Clinical Trial AssociateCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · Clinical · posted OCT 28, 2026
- Clinical Trial ManagerCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · Clinical · posted OCT 28, 2026
- Sr Product Security EngineerCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · IT · posted OCT 20, 2026
- Senior Systems EngineerCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · Engineering · posted OCT 13, 2026
- Electrical EngineerCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · Engineering · posted SEP 14, 2026
- Mechanical EngineerCognito Therapeutics Group, INC. · Cambridge, MA - Hybrid · Remote · Engineering · posted SEP 11, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
19 US patents granted 2010–2025, 6 of them in the five years to SEP 2025.
Medical technology 7Pharmaceuticals 6Organic fine chemistry 6
- Methods and systems for neural stimulation via visual, auditory and peripheral nerve stimulationsUS 12,383,759 · granted AUG 12, 2025
- Compositions for treating neurodegenerative diseasesUS 11,981,636 · granted MAY 14, 2024
- Isoindoline compositions and methods for treating neurodegenerative diseaseUS 11,691,947 · granted JUL 4, 2023
- Compositions for treating neurodegenerative diseasesUS 11,214,540 · granted JAN 4, 2022
- Methods and systems for neural stimulation via visual stimulationUS 11,141,604 · granted OCT 12, 2021
Newest 5 shown · Granted to Cognito Therapeutics, INC. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Cognito Therapeutics Group, INC. | Cambridge | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.